Phase I clinical trial shows some promise for investigational drug for melanoma

(UNC Lineberger Comprehensive Cancer Center) In JCI Insight, UNC Lineberger's Stergios Moschos, MD, and colleagues published the results of a phase I, multi-institution clinical trial for an investigational treatment for melanoma and other cancers with mutations in the BRAF or RAS genes.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news